Assessment of the discriminative stimulus effects of the D3 dopamine antagonist PNU-99194A in rats: Comparison with psychomotor stimulants

Behavioural Pharmacology

Volumn 8, Issue 2-3, 1997, Pages 243-252

  Baker, L E ^a   Miller, M E ^a   Svensson, K A ^b  

^a WESTERN MICHIGAN UNIVERSITY   (United States)

^b PFIZER INC   (United States)

Author keywords

Caffeine; Cocaine; d Amphetamine; D3 dopamine receptors; PNU 99194A; Psychostimulants; Rat

Indexed keywords

2 DIPROPYLAMINO 5,6 DIMETHOXYINDAN; CAFFEINE; COCAINE; DEXAMPHETAMINE; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; PSYCHOSTIMULANT AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; REINFORCEMENT; STIMULUS GENERALIZATION; SUBCUTANEOUS DRUG ADMINISTRATION; SUBSTANCE ABUSE;

AMPHETAMINE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; DISCRIMINATION (PSYCHOLOGY); DISCRIMINATION LEARNING; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; INDANS; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; STIMULATION, CHEMICAL;

EID: 0030738533     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Acri JB, Carter S, Ailing K, Geter-Douglass B, Dijkstra D, Wikstrom H, Katz J and Witkin J (1995) Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands. European Journal of Pharmacology, 281, R7-R9.
2. Baker LE, Riddle EE, Saunders RB and Appel JB (1993) The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds. Behavioural Pharmacology, 4, 69-79.
3. Barrett RL and Appel JB (1989) Effects of stimulation and blockade of dopamine receptor subtypes on the discriminative stimulus properties of cocaine. Psychopharmacology, 99, 13-16.
4. Caine SB and Koob GF (1995) Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat. Behavioural Pharmacology, 6, 333-347.
5. Callahan PM and Cunningham KA (1993) Discriminative stimulus properties of cocaine in relation to dopamine D2 receptor function in rats. Journal of Phamacology and Experimental Therapeutics, 266, 585-592.
6. Callahan PM, Appel JB and Cunningham KA (1991) Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine. Psychopharmacology, 103, 50-55.
7. Callahan PM, Piercey MF and Cunningham KA (1992) Effects of putative dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 on the discriminative stimulus properties of cocaine. Psychopharmacology, 107, 73-77.
8. Clark D, Exner M, Furmidge LJ, Svensson K and Sonesson C (1995) Effects of the dopamine autoreceptor antagonist (-)-DS 121 on the discriminative stimulus properties of damphetamine and cocaine. European Journal of Pharmacology, 275, 67-74.
9. Colpaert FC, Niemegeers CJE and Janssen PAJ (1978) Neuroleptic interference with the cocaine cue: internal stimulus control of behavior and psychosis. Psychopharmacology, 58, 247-255.
10. Colpaert FC, Niemegeers CJE and Janssen PAJ (1979) Discriminative stimulus properties of cocaine: neuropharmacological characteristics as derived from stimulus generalization experiments. Pharmacology Biochemistry and Behaviour, 10, 535-546.
11. Daly SA and Waddington JL (1993) Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other "D-2-like" agonists. Neuropharmacology, 32, 509-510.
12. Extance K and Goudie AJ (1981) Inter-animal olfactory cues in operant drug discrimination procedures in rats. Psychopharmacology, 91, 67-73.
13. Kleber HD (1995) Pharmacotherapy, current and potential, for the treatment of cocaine dependence. Clinical Neuropharmacology, 18, S96-S109.
14. Kleven MS, Anthony EW and Woolverton WL (1990) Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics, 254, 312-317.
15. Kling-Petersen T, Ljung E, Wollter L and Svensson K (1995a) Effects of the dopamine D3- and autoreceptor preferring antagonist (-)-DS 121 on locomotor activity, conditioned place preference and intracranial self-stimulation in the rat. Behavioural Pharmacology, 6, 107-115.
16. Kling-Petersen T, Ljung E, Wollter L and Svensson K (1995b) Effects of dopamine D3 preferring compounds on conditioned place preference and intracranial self-stimulation in the rat. Journal of Neural Transmission, 101, 27-39.
17. Levesque D, Diaz J, Pilon C, Martres M, Giros B, Souil E, Schott D, Morgat J, Schwartz J and Sokolof P (1992) Identification, characterization and localization of the dopamine D3 receptor in rat brain using 7-[3H]-hydroxy-N,N-di-n-propyl-2-aminotetralin. Proceedings of National Academy of Science, 89, 8155-8159.
18. Mallet PE and Beninger RJ (1994) 7-OH-DPAT produces place conditioning in rats. European Journal of Pharmacology, 261, R5-R6.
19. McKenna ML and Ho BT (1980) The role of dopamine in the discriminative stimulus properties of cocaine. Neurophar-macology, 19, 297-303.
20. Parsons LH, Caine SB, Sokoloff P, Schwartz JC, Koob GF and Weiss F (1996) Neurochemical evidence that postsynaptic nucleus accumbens D-3 receptor stimulation enhances cocaine reinforcement. Journal of Neurochemistry, 3, 1078-1089.
21. Piercey MF, Lum JT, Hoffmann WE, Carlsson A, Ljung E and Svensson K (1992) Antagonism of cocaine's pharmacological effects by the stimulant dopaminergic antagonists, (+)-AJ76 and (+)-UH 232. Brain Research, 588, 217-222.
22. Richardson NR, Piercey MF, Svensson K, Collins RJ, Myers JE and Roberts DCS (1993) Antagonism of cocaine self-administration by the preferential dopamine autoreceptor antagonist, (+)-AJ 76. Brain Research, 619, 15-21.
23. Roberts DCS and Ranaldi R (1995) Effect of dopaminergic drugs on cocaine reinforcement. Clinical Neuropharmacology, 18, S84-S95.
24. Sibley DR and Monsma JR (1992) Molecular biology dopamine receptors. Trends in Pharmacological Sciences, 13, 61-69.
25. Smith A, Piercey MF and Roberts DCS (1995) Effects of (-)DS 121 and (+)-UH 232 on cocaine self-administration in rats. Psychopharmacology, 120, 93-98.
26. Sokoloff P, Giros B, Martres MP, Bouthenet ML and Schwartz JC (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature, 347, 146-151.
27. Spealman RD, Bergman J, Madras BK and Melia KF (1991) Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes. Journal of Pharmacology and Experimental Therapeutics, 258, 945-953.
28. Svensson K, Johansson AM, Magnusson T and Carlsson A (1986) (+)-AJ76 and (+)-UH232: central stimulants acting as preferential dopamine autoreccptor antagonists. Naunyn-Schmiedeberys Archives of Pharmacology, 33, 234-245.
29. Svensson K, Waters N, Sonesson C, Wikstrom H. Nichols N and Carlsson A (1993)(-)-DS121, a novel dopamine D3-and autoreceptor preferring antagonist: effects on locomotor activity in the rat. Society for Neuroscience Abstracts, 19, 80.
30. Svensson K, Carlsson A, Huff RM, Kling-Petersen T and Waters N (1994a) Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors. European Journal of Pharmacology, 263, 235-243.
31. Svensson K, Carlsson A and Waters N (1994b) Locomotor inhibition by the D3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release. Journal of Neural Transmission, 95, 71-74.
32. Waters N, Svensson K, Haadsma-Svensson SR, Smith MW and Carlsson A (1993) The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. Journal of Neural Transmission, 94, 11-19.
33. Witkin JM (1994) Pharmacotherapy of cocaine abuse: preclinical development. Neuroscience Biobehavioral Reviews, 18, 121-142.
34. Witkin JM, Nichols DE, Terry P and Katz JL (1991) Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. Journal of Pharmacology and Experimental Therapeutics, 257, 706-713.